EMEA-003248-PIP01-22

Table of contents

Key facts

Active substance
Suvecaltamide (hydrochloride)
Therapeutic area
Neurology
Decision number
P/0372/2022
PIP number
EMEA-003248-PIP01-22
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of essential tremor
Route(s) of administration
Oral use
Contact for public enquiries
Jazz Pharmaceuticals Ireland Ltd.

E-mail: corporateaffairsmediainfo@jazzpharma.com
Telephone: +1 35316347800

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating
Average
1 rating